Future Financial Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Future Financial Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-200	Closed	-$27.4K	–	258
2024 Q1	$27.4K	Buy	+200	New	+$27.3K	0.02%	318
2022 Q2	–	Sell	-276	Closed	-$36K	–	276
2022 Q1	$36K	Buy	276 +76	+38%	+$9.9K	0.03%	306
2021 Q4	$30K	Buy	+200	New	+$31K	0.02%	332

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Future Financial Wealth Management's IBB Position: Q2 2024 in Review

Future Financial Wealth Management sold out of iShares Biotechnology ETF (IBB) in Q2 2024, closing a stake of 200 shares — an estimated $27.4K sold.

Future Financial Wealth Management first reported a position in IBB in Q4 2021 and held it in 3 quarters. The position peaked at $36K in Q1 2022. 894 funds tracked by Wall St. Rank hold IBB as of Q2 2024.

Future Financial Wealth Management reported no remaining iShares Biotechnology ETF position as of Q2 2024 after selling out during the quarter.
Future Financial Wealth Management sold 200 iShares Biotechnology ETF shares in Q2 2024, an estimated $27.4K.
Future Financial Wealth Management first reported a position in iShares Biotechnology ETF in Q4 2021 and held it in 3 quarters.
Future Financial Wealth Management's iShares Biotechnology ETF position peaked at $36K in Q1 2022.
894 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2024.

Based on Future Financial Wealth Management's 13F filing for Q2 2024, filed 16 Jul 2024.